CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. BLOOD SCREENING HCV PROBE LICENSE AGREEMENT— EUROPEAN UNION between CHIRON...HCV Probe License Agreement • August 12th, 2003 • Chiron Corp • Pharmaceutical preparations
This agreement (hereinafter "Agreement") is made by and between CHIRON CORPORATION, a Delaware corporation, of 4560 Horton Street, Emeryville, California 94608 (hereinafter referred to as "CHIRON"), F. HOFFMANN-LA ROCHE LTD., a Swiss corporation, of Grenzacherstrasse 124, Basel, Switzerland (hereinafter referred to as "ROCHE PARENT"), and ROCHE MOLECULAR SYSTEMS, INC., a Delaware corporation, of 1145 Atlantic Avenue, Suite 100, Alameda, California 94501 (hereinafter referred to as "RMS" and collectively with ROCHE PARENT, "ROCHE").
BLOOD SCREENING HCV PROBE LICENSE AGREEMENT between CHIRON CORPORATION and ROCHE MOLECULAR SYSTEMS, INC.HCV Probe License Agreement • August 8th, 2001 • Chiron Corp • Pharmaceutical preparations
This agreement (hereinafter "Agreement") is made by and between CHIRON CORPORATION, a Delaware corporation, of 4560 Horton Street, Emeryville, California 94608 (hereinafter referred to as "CHIRON"), F. HOFFMANN-LA ROCHE LTD., a Swiss corporation, of Grenzacherstrasse 124, Basel, Switzerland (hereinafter referred to as "ROCHE PARENT"), and ROCHE MOLECULAR SYSTEMS, INC., a Delaware corporation, of 1145 Atlantic Avenue, Suite 100, Alameda, California 94501 (hereinafter referred to as "RMS" and collectively with ROCHE PARENT, "ROCHE").
REDACTED EXHIBIT 10.307 **CONFIDENTIAL TREATMENT REQUESTED** HCV PROBE LICENSE AGREEMENTHCV Probe License Agreement • November 7th, 2000 • Chiron Corp • Pharmaceutical preparations
